Research from the likes of Pfizer, Decibel, Capsida Bio, Freeline Tx, Takeda, and more show that it is clear companies are discovering that prioritizing the monitoring and evaluation of both pre clinical and clinical safety signals in gene therapy treatments is critical to success as more genetic therapies enter the pipeline.
To support them with this safety research and analysis, gene therapy developers are looking for:
- Preclinical Research & Toxicology Testing (CROs)
- Sequencing Companies
- Clinical CROs
Partnering with us provides a unique platform to showcase how your services align with gene therapy companies that are looking to strike the balance between efficacy and safety through comprehensive pre clinical research and toxicology testing to clinical trial management and beyond.
Partner with us for the opportunity to connect with the key decision-makers within the gene therapy safety community to demonstrate thought leadership, drive brand exposure, and build long-term collaborative relationships with this highly focused audience.
Get in touch today to learn more about how we can build a bespoke partnership to support your business development objectives.